Shanghai Bio-heart Biological Technology Co., Ltd. plans to abolish its Board of Supervisors and shift the oversight role to the Board’s audit committee, according to a filing made under Hong Kong Listing Rule 13.51(1).

The restructuring proposal, driven by amendments to the PRC Company Law effective 1 July 2024, will be put to shareholders as special resolutions at the 26 June 2026 annual general meeting (AGM). If approved, the new Articles of Association will reflect: 1) replacement of the Board of Supervisors with the audit committee; 2) strengthened minority-shareholder protections; 3) alignment with updated regulatory requirements; and 4) other consequential and housekeeping changes.

All current supervisors have agreed to resign once the changes take effect and have stated they hold no disagreements with the Board.

To determine shareholder eligibility to vote at the AGM, the H-share register will close from 15 June to 26 June 2026, with share transfer documents required by 4:30 p.m. on 12 June 2026 at Computershare Hong Kong Investor Services Limited.

A circular detailing the proposed governance overhaul and the AGM notice is scheduled for distribution on or around 2 June 2026.